Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1988 Nov 1;139(9):837-44.

Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin

Affiliations
Review

Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin

S P Kraft et al. CMAJ. .

Abstract

Blepharospasm, the most frequent feature of cranial dystonia, and hemifacial spasm are two involuntary movement disorders that affect facial muscles. The cause of blepharospasm and other forms of cranial dystonia is not known. Hemifacial spasm is usually due to compression of the seventh cranial nerve at its exit from the brain stem. Cranial dystonia may result in severe disability. Hemifacial spasm tends to be much less disabling but may cause considerable distress and embarrassment. Patients affected with these disorders are often mistakenly considered to have psychiatric problems. Although the two disorders are quite distinct pathophysiologically, therapy with botulinum toxin has proven very effective in both. We review the clinical features, proposed pathophysiologic features, differential diagnosis and treatment, including the use of botulinum toxin, of cranial dystonia and hemifacial spasm.

PubMed Disclaimer

References

    1. Trans Am Acad Ophthalmol Otolaryngol. 1967 Jul-Aug;71(4):656-64 - PubMed
    1. Am J Ophthalmol. 1968 Jun;65(6):889-90 - PubMed
    1. Arch Neurol. 1971 Jul;25(1):81-7 - PubMed
    1. Geriatrics. 1972 Aug;27(8):69-73 - PubMed
    1. Adv Neurol. 1976;14:245-58 - PubMed

MeSH terms

Substances